Cargando…
mAb14, a Monoclonal Antibody against Cell Surface PCNA: A Potential Tool for Sezary Syndrome Diagnosis and Targeted Immunotherapy
SIMPLE SUMMARY: We need better ways to detect and treat skin lymphoma, a type of skin cancer. Current treatments that enhance the body’s cancer-fighting abilities are not very effective, and the markers used for diagnosis are not specific. We’ve previously found a new marker called PCNA on the surfa...
Autores principales: | Knaneh, Jamal, Hodak, Emmilia, Fedida-Metula, Shlomit, Edri, Avishay, Eren, Rachel, Yoffe, Yael, Amitay-Laish, Iris, Prag Naveh, Hadas, Lubin, Ido, Porgador, Angel, Moyal, Lilach |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486495/ https://www.ncbi.nlm.nih.gov/pubmed/37686697 http://dx.doi.org/10.3390/cancers15174421 |
Ejemplares similares
-
Stage-dependent Increase in Expression of miR-155 and Ki-67 and Number of Tumour-associated Inflammatory Cells in Folliculotropic Mycosis Fungoides
por: ATZMONY, Lihi, et al.
Publicado: (2020) -
The Therapeutic Potential of AN-7, a Novel Histone Deacetylase Inhibitor, for Treatment of Mycosis Fungoides/Sezary Syndrome Alone or with Doxorubicin
por: Moyal, Lilach, et al.
Publicado: (2016) -
Melanoma Risk is Increased in Patients with Mycosis Fungoides Compared with Patients with Psoriasis and the General Population
por: SHERMAN, Shany, et al.
Publicado: (2020) -
Sudan ebolavirus long recovered survivors produce GP-specific Abs that are of the IgG1 subclass and preferentially bind FcγRI
por: Radinsky, Olga, et al.
Publicado: (2017) -
Synergistic cytotoxic activity of cannabinoids from cannabis sativa against cutaneous T-cell lymphoma (CTCL) in-vitro and ex-vivo
por: Mazuz, Moran, et al.
Publicado: (2020)